v3 Template
N

Nuvalent, Inc.

Biotechnology / Healthcare CAMBRIDGE, Mass. ~3K employees
Founded
--
Employees (Est.)
~3K
151 leaders known
Total Funding
$2.9B
Funding Rounds
6
Last Funding
2025-11-24

About Nuvalent, Inc.

Nuvalent is a company focused on creating precisely targeted therapies for patients with cancer, leveraging deep expertise in chemistry and structure-based drug discovery to address resistance and selectivity challenges.

Products & Services

Zidesamtinib (NVL-520):A Phase 1/2 study for patients with advanced ROS1-positive NSCLC and other solid tumors.

Specialties

Chemistry Structure-based Drug Discovery Targeted Cancer Therapies Kinase Inhibition

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering 		A: 500000000
MR: -
FA: approximately $500.0 million
FAN: 500000000 		D: 2025-11-24
FD: 2025-11-24 		4 investors
2 RT: Public Offering
T: -
FT: Public Offering 		A: 500000000
MR: -
FA: approximately $500.0 million
FAN: 500000000 		D: 2025-11-18
FD: 2025-11-18 		6 investors
3 RT: Public Offering
T: -
FT: Public Offering 		A: 500000000
MR: -
FA: 500.0 million
FAN: 500000000 		D: 2025-11-17
FD: 2025-11-17 		2 investors
4 RT: Public Offering
T: -
FT: Public Offering 		A: 575000000
MR: -
FA: approximately $575.0 million
FAN: 575000000 		D: 2024-09-18
FD: 2024-09-18 		4 investors
5 RT: Public Offering
T: -
FT: Public Offering 		A: 350000000
MR: -
FA: $350.0 million
FAN: 350000000 		D: 2024-09-16
FD: 2024-09-16 		4 investors
6 RT: Public Offering
T: -
FT: Public Offering 		A: 500000000
MR: -
FA: 500 million USD
FAN: 500000000 		D: 2024-09-16
FD: 2024-09-16 		4 investors
Public Offering Latest
2025-11-24
$500.0M
4 investors (Pro only)
Public Offering 2025-11-18
$500.0M
Public Offering 2025-11-17
$500.0M

View 5 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

R

Ruth Adams

Senior Vice President, Clinical Operations

J

Jason Agostinelli

Finance

M

Michael Alos

Information Technology

K

Kari Andrews

Clinical Operations

K

Kristin Andrews

Chemistry

M

Molly Araujo

Commercial Operations

View 148 more team members with Pro

Unlock Full Team Directory

Recent News

Nuvalent, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Healthcare
Company Size
~3K employees (est.)
Locations
CAMBRIDGE, Mass.
Cambridge, Mass.
Cambridge, Mass., USA

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro